Pyxis Oncology, Inc. Common Stock Share Price
NASDAQ: PYXSHealthcare
Live Pyxis Oncology, Inc. Common Stock Share Price Chart
O H L
Pyxis Oncology, Inc. Common Stock Performance Overview
Days Range
▼
$3.38Low
$3.42High
Markets Today
| Previous Close | $3.41 |
|---|---|
| Open | $3.42 |
| Volume | 18,888 |
| Day's Range | $3.38 - $3.42 |
| 52W Range | $1.03 - $5.55 |
| Market Cap | $278.58 M |
Historical Performance
| 1M Returns | +14.05 |
|---|---|
| 3M Returns | +67.98 |
| 6M Returns | +122.88 |
| 1Y Returns | +46.98 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Pyxis Oncology, Inc. Common Stock Fundamentals
| Market Cap | $278.58 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $13.86 M |
| ROE TTM | -0.91 |
| EPS TTM | $-1.40 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 18.52 |
| EBITDA | $-79.91 M |
| Profit Margin | -574.55 |
| Market Cap | $278.58 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $13.86 M |
| ROE TTM | -0.91 |
| EPS TTM | $-1.40 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 18.52 |
| EBITDA | $-79.91 M |
| Profit Margin | -574.55 |
Pyxis Oncology, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $2.82 M | $0 | $11.04 M | $0 | $0 |
| Gross Profit + | $0 | $2.82 M | $0 | $8.65 M | $0 | $0 |
| Operating Income | -$22.91 M | -$19.75 M | -$23.46 M | -$18.30 M | -$24.36 M | -$25.99 M |
| EBITDA | -$22.36 M | -$19.21 M | -$22.93 M | -$15.40 M | -$23.90 M | -$25.69 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $552.00 K | $535.00 K | $527.00 K | $2.90 M | $459.00 K | $301.00 K |
| Income Before Tax | -$21.16 M | -$18.07 M | -$22.00 M | -$17.00 M | -$23.27 M | -$25.35 M |
| Income Tax Expense | $0 | $283.00 K | $0 | $1.10 M | $0 | $0 |
| Net Income + | -$21.16 M | -$18.35 M | -$22.00 M | -$18.11 M | -$23.27 M | -$25.35 M |
| Net Profit Margin | - | -650.85% | - | -164.03% | - | - |
Pyxis Oncology, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $62.00 K | $62.00 K | $62.00 K | $63.00 K | $63.00 K | $63.00 K |
| Reserve & Surplus | -$384.67 M | -$403.07 M | -$425.00 M | -$443.12 M | -$466.45 M | -$491.80 M |
| Non-Current Liabilities | $18.33 M | $17.89 M | $17.44 M | $16.98 M | $16.50 M | $16.01 M |
| Current Liabilities | $14.43 M | $17.68 M | $19.38 M | $21.13 M | $16.53 M | $27.47 M |
| Total Liabilities | $32.76 M | $35.57 M | $36.83 M | $38.11 M | $33.03 M | $43.48 M |
| Fixed Assets | $11.95 M | $11.41 M | $10.89 M | $8.00 M | $7.54 M | $7.24 M |
| Current Assets | $111.87 M | $99.96 M | $83.07 M | $72.11 M | $45.57 M | $36.73 M |
| Total Assets | $135.87 M | $123.22 M | $105.60 M | $91.52 M | $64.30 M | $54.92 M |
Pyxis Oncology, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$21.16 M | -$18.35 M | -$22.00 M | -$18.11 M | -$23.27 M | -$25.35 M |
| Operating Cash Flow | -$22.54 M | -$17.26 M | -$13.28 M | -$10.43 M | -$26.00 M | -$18.21 M |
| Investing Cash Flow | $15.82 M | $15.30 M | $11.47 M | $16.26 M | $16.37 M | $21.30 M |
| Financing Cash Flow | $0 | -$67.00 K | -$8.00 K | $669.00 K | -$25.00 K | $9.99 M |
| Change in Cash | -$6.71 M | -$2.03 M | -$1.81 M | $6.50 M | -$9.66 M | $13.09 M |
Pyxis Oncology, Inc. Common Stock Return Calculator
The Pyxis Oncology, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Pyxis Oncology, Inc. Common Stock
Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly PYX-201), is an investigational antibody-drug conjugate that targets extradomain-B fibronectin (EDB+FN), a component of the tumor extracellular matrix that is expressed in tumors and minimally present in normal tissues. MICVO consists of a fully human monoclonal antibody linked to a microtubule inhibitor payload, designed to bind within the tumor microenvironment and release its payload to kill cancer cells directly, affect nearby cells through a bystander effect, and induce immunogenic cell death, supporting enhanced anti-tumor activity.
Popular Stocks
FAQs
What is the share price of Pyxis Oncology, Inc. Common Stock today?
Pyxis Oncology, Inc. Common Stock (PYXS) share price as of September 18, 2026 is $3.30. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Pyxis Oncology, Inc. Common Stock?
Yes, Indian Investors can invest in the Pyxis Oncology, Inc. Common Stock (PYXS) Share by opening an international trading account with Angel One.
How can I purchase Pyxis Oncology, Inc. Common Stock shares in India?
Purchasing Pyxis Oncology, Inc. Common Stock (PYXS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Pyxis Oncology, Inc. Common Stock (PYXS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Pyxis Oncology, Inc. Common Stock?
Yes, you can purchase fractional shares of Pyxis Oncology, Inc. Common Stock (PYXS) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Pyxis Oncology, Inc. Common Stock?
The market capitalization of Pyxis Oncology, Inc. Common Stock on September 18, 2026, is $278.58 M.
In which sector Pyxis Oncology, Inc. Common Stock belongs?
Pyxis Oncology, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Pyxis Oncology, Inc. Common Stock stocks?
In order to invest in Pyxis Oncology, Inc. Common Stock (PYXS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
